Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest Articles
Tsuchiya D et al. – The visual acuity after photodynamic therapy in AMD patients was maintained for 2 years after the initial treatment. Patients with AMD + PCV had stable visual outcome within 1 year but not after 1 year; there are risks of late recurrences and massive hemorrhages after 1 year in patients with AMD + PCV.
Related Articles
Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration
Retina, 11/11/09
Relevance Score: 68%
Statin Use and the Incidence of Advanced Age-Related Macular Degeneration in the Complications of Age-Related Macular Degeneration Prevention Trial
Ophthalmology, 10/28/09
Relevance Score: 68%
siRNA therapeutics for age-related macular degeneration: promises and pitfalls
Expert Review of Ophthalmology, 10/22/09
Relevance Score: 68%
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09
Relevance Score: 67%
Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections
Acta Ophthalmologica, 11/11/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral ganciclovir as maintenance treatment of macular CMV-retinitis
Spektrum der Augenheilkunde, 12/17/09
Alterations in the Intraocular Cytokine Milieu Following Intravitreal Bevacizumab
Investigative Ophthalmology and Visual Science, 12/17/09
Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Management and outcome of unilateral retinoblastoma
Journal of American Association for Pediatric Ophthalmology and Strabismus , 12/17/09
Oral ganciclovir as maintenance treatment of macular CMV-retinitis
Spektrum der Augenheilkunde, 12/17/09
Alterations in the Intraocular Cytokine Milieu Following Intravitreal Bevacizumab
Investigative Ophthalmology and Visual Science, 12/17/09
Article Search
Sponsor